Trial intelligence / Profile preview

Double Stimulation in Poor Ovarian Responders

NCT02732808Phase 3Completed

Sponsor
Royan Institute
Start
Sep 2014
Primary completion
Apr 2016
Modality
Recombinant Proteins and Enzymes, Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of clomiphene, letrozole, menotropins, medroxyprogesterone acetate in infertility, poor ovarian response (POR), sponsored by Royan Institute. Started Sep 2014; status: completed.

02

Drugs

clomipheneletrozolemenotropinsmedroxyprogesterone acetate
03

Conditions

infertilitypoor ovarian response (POR)

Beyond the preview

Go deeper on NCT02732808.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02732808.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call